These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
382 related items for PubMed ID: 31429792
1. Covered stents versus Bare-metal stents in chronic atherosclerotic Gastrointestinal Ischemia (CoBaGI): study protocol for a randomized controlled trial. van Dijk LJD, Harki J, van Noord D, Verhagen HJM, Kolkman JJ, Geelkerken RH, Bruno MJ, Moelker A, Dutch Mesenteric Ischemia Study group (DMIS). Trials; 2019 Aug 20; 20(1):519. PubMed ID: 31429792 [Abstract] [Full Text] [Related]
3. Covered versus bare-metal stenting of the mesenteric arteries in patients with chronic mesenteric ischaemia (CoBaGI): a multicentre, patient-blinded and investigator-blinded, randomised controlled trial. Terlouw LG, van Dijk LJD, van Noord D, Bakker OJ, Bijdevaate DC, Erler NS, Fioole B, Harki J, van den Heuvel DAF, Hinnen JW, Kolkman JJ, Nikkessen S, van Petersen AS, Smits HFM, Verhagen HJM, de Vries AC, de Vries JPM, Vroegindeweij D, Geelkerken RH, Bruno MJ, Moelker A, Dutch Mesenteric Ischemia Study Group. Lancet Gastroenterol Hepatol; 2024 Apr 20; 9(4):299-309. PubMed ID: 38301673 [Abstract] [Full Text] [Related]
4. Improving midterm results justify the continued use of bare-metal stents for endovascular therapy for chronic mesenteric ischemia. Haben C, Park WM, Bena JF, Parodi FE, Lyden SP. J Vasc Surg; 2020 Jan 20; 71(1):111-120. PubMed ID: 31327617 [Abstract] [Full Text] [Related]
7. Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia. Fioole B, van de Rest HJ, Meijer JR, van Leersum M, van Koeverden S, Moll FL, van den Berg JC, de Vries JP. J Vasc Surg; 2010 Feb 20; 51(2):386-91. PubMed ID: 19889510 [Abstract] [Full Text] [Related]
8. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. Mwipatayi BP, Sharma S, Daneshmand A, Thomas SD, Vijayan V, Altaf N, Garbowski M, Jackson M, COBEST co-investigators. J Vasc Surg; 2016 Jul 20; 64(1):83-94.e1. PubMed ID: 27131926 [Abstract] [Full Text] [Related]
9. Reinterventions for stent restenosis in patients treated for atherosclerotic mesenteric artery disease. Tallarita T, Oderich GS, Macedo TA, Gloviczki P, Misra S, Duncan AA, Kalra M, Bower TC. J Vasc Surg; 2011 Nov 20; 54(5):1422-1429.e1. PubMed ID: 21963821 [Abstract] [Full Text] [Related]
10. Long-Term Outcomes of Mesenteric Stenting and Analysis of In-Stent Restenosis Duplex Velocity Criteria. Barnes JA, Columbo JA, Ponukumati AS, Zwolak RM, Olive FT, Goodney PP, Powell RJ, Zacharias N. Ann Vasc Surg; 2020 Oct 20; 68():226-233. PubMed ID: 32428638 [Abstract] [Full Text] [Related]